Pharmacologic Management of Benign Prostatic Hyperplasia (BPH)

First‑Line Therapy Selection

Indications for Finasteride (5‑α‑Reductase Inhibitor)

Comparative Efficacy

Combination Therapy (Tamsulosin + Finasteride)

Safety Considerations

Tamsulosin‑Specific

Finasteride‑Specific

Common Clinical Pitfalls

Management of Inadequate Response to Monotherapy